Chemoinformaics analysis of xi-3,5-Dimethyl-2(5H)-furanone
| Molecular Weight | 112.128 | nRot | 0 |
| Heavy Atom Molecular Weight | 104.064 | nRig | 5 |
| Exact Molecular Weight | 112.052 | nRing | 1 |
| Solubility: LogS | -0.697 | nHRing | 1 |
| Solubility: LogP | 1.356 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 16.9583 |
| nHD | 0 | BPOL | 10.6297 |
| QED | 0.553 |
| Synth | 2.836 |
| Natural Product Likeliness | 0.266 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.021 |
| HIA | 0.004 |
| CACO-2 | -4.574 |
| MDCK | 0.0000228 |
| BBB | 0.261 |
| PPB | 0.869503 |
| VDSS | 1.167 |
| FU | 0.235273 |
| CYP1A2-inh | 0.367 |
| CYP1A2-sub | 0.829 |
| CYP2c19-inh | 0.05 |
| CYP2c19-sub | 0.562 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.733 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.842 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.263 |
| CL | 13.855 |
| T12 | 0.852 |
| hERG | 0.003 |
| Ames | 0.008 |
| ROA | 0.116 |
| SkinSen | 0.337 |
| Carcinogencity | 0.861 |
| EI | 0.948 |
| Respiratory | 0.124 |
| NR-Aromatase | 0.014 |
| Antiviral | No |
| Prediction | 0.941861 |